peakFrontier powers everything
Seven years of clinical validation. Five million expert annotations. One frontier model.
.webp)
The Core of Every Discovery
Built on our proprietary AI architecture to extract deep tissue and cell features across all staining modalities.
As the engine powering our entire product portfolio, peakFrontier turns complex pathology images into objective, reproducible data, accelerating the journey from biomarker discovery to clinical diagnostics.
A Stepwise Path to Insight
From raw image to actionable cell-level intelligence
Input (mIF, IHC, or H&E)
The model accepts high-resolution images from all major staining modalities.
Tissue Segmentation
AI analysis segments tissue into 12 distinct, clinically relevant classes.
Cell Classification
Individual cells are detected and classified into 13 distinct types, enabling accurate phenotyping.
Sub-Cellular Segmentation
Nucleus, cytoplasm and membrane are segmented, enabling accurate quantification of biomarker expression.
Seven years of development. Five million annotations. Twelve tissue types.
5M
Expert annotations
12
Tissue region types
7
Years of validation
Our end-to-end suite. Built on peakFrontier
Every tool in the Mindpeak portfolio runs on peakFrontier, a proprietary frontier model that uncovers target biomarkers and reveals mechanisms of action. From discovery to deployment, one model powers them all.
One Model.
A Universe of Applications
See how the power of peakFrontier is harnessed across our specialized toolset
Find the Unseen Signature
Go beyond standard scoring. peakDiscover extracts deep tissue and cell features across mIF, IHC, and H&E to characterize the Tumor Microenvironment (TME).
Identify novel biomarker signatures and spatial patterns invisible to the human eye to better understand drug mechanism of action.
Immediate Global Scale
Don't let infrastructure be your barrier to entry. With 18+ IMS partner integrations and presence in 40+ labs worldwide, Mindpeak provides an "instant-on" commercial ecosystem.
We ensure your CDx is accessible to clinicians globally from day one. This established network provides partners with immediate access to the market.
Standardize Global Adoption
Empower the medical community with a digital masterclass platform designed to train pathologists on your biomarkers using AI-assisted trainings. Ensure that every pathologist, regardless of location, can accurately identify the patients who will benefit most from your therapy.
peakAcademy is already actively supporting biomarker training programs with biopharma across more than 20 countries.
Optimize tissue selection for testing
AI-assisted macro dissection guides tissue routing to molecular assays. Reduce waste, improve precision.
Algorithmic Precision for Diagnostic Confidence
Standardize your routine IHC and H&E diagnostics with our full suite of clinical-grade AI algorithms. From comprehensive breast cancer profiling to a tissue-agnostic pan-tumor portfolio, peakDecision provides automated, reproducible scoring that eliminates reader variability and accelerates case turnaround.
Confidently identify more eligible patients for targeted therapies through precise cell classification and zero-click whole-slide analysis. Designed for seamless clinical integration, our diagnostic tools empower your lab to deliver high-confidence results at scale across all solid tumor indications.
Precision Patient Selection
Standardize your trial endpoints. By using predictive AI assays to quantify biomarker expression, you eliminate the "location bias" of manual reads, ensuring the right patients are enrolled and your therapy’s efficacy is clearly demonstrated.
Find the Unseen Signature
Go beyond standard scoring. peakDiscover extracts deep tissue and cell features across mIF, IHC, and H&E to characterize the Tumor Microenvironment (TME). Identify novel biomarker signatures and spatial patterns invisible to the human eye to better understand drug mechanism of action.
peakDiscover
Precision Patient Selection
Standardize your trial endpoints. By using predictive AI assays to quantify biomarker expression, you eliminate the "location bias" of manual reads, ensuring the right patients are enrolled and your therapy’s efficacy is clearly demonstrated.
peakPredict
Algorithmic Precision for Diagnostic Confidence
Standardize IHC and H&E workflows with our clinical-grade AI. Our peakDecision platform provides automated, reproducible scoring that eliminates reader variability and speeds up case turnaround. Identify more eligible patients through precise cell classification and zero-click whole-slide analysis. Seamlessly integrated, our tools empower your lab to deliver high-confidence results at scale across all solid tumor indications.
peakDx
Precision Pre-Analytics for Molecular Testing
peakDissect is an AI-assisted macro dissection tool optimizing tissue selection for molecular testing.
peakDissect
Immediate Global Scale
Don't let infrastructure be your barrier to entry. With 18+ IMS partner integrations and presence in 40+ labs worldwide, Mindpeak provides an "instant-on" commercial ecosystem. We ensure your CDx is accessible to clinicians globally from day one. This established network provides partners with immediate access to the market.
.jpg)
peakDeploy
Standardize Global Adoption
Empower the medical community with a digital masterclass platform designed to train pathologists on your biomarkers using AI-assisted trainings. Ensure that every pathologist, regardless of location, can accurately identify the patients who will benefit most from your therapy. peakAcademy is already actively supporting biomarker training programs with biopharma across more than 20 countries.
peakAcademy
Is your lab ready to build on peakFrontier?
Request a technical demo, or speak with our science team today.